NOVAVAX2019 新冠肺炎疫苗的紧急使用授权 (EUA) for the prevention of 2019 coronavirus

Novavax2019 coronavirus vaccine is an unapproved vaccine that can prevent 2019 coronavirus. The vaccine has been authorized for emergency use by the US Food and Drug Administration (FDA) as a primary series for the prevention of 2019 coronavirus in individuals 12 years of age and older and as a first booster dose for individuals 18 years of age and older under an emergency use authorization.


File format
PDF
Published
30 October, 2023
Updated
30 October, 2023
MD5 checksum
F4AAE1A8F49671B7DDDCA07FC5B5B29E
Download PDF

Also Manuals